Tri Chemical Laboratories Inc.'s next confirmed earnings release is scheduled for November 30, 2026.
| Earnings Date | 11/30/2026 |
As of July 31, 2026, Tri Chemical Laboratories Inc. has 32.50M shares outstanding.
| Shares Outstanding | 32.50M |
As of July 31, 2026, Tri Chemical Laboratories Inc. maintains a current ratio of 4.37, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.37 |
| Quick Ratio | 1.80 |
| Debt / Equity | 15.12 |
These figures cover the twelve months ended July 31, 2026.
| Employee Count | 303.25 |
As of July 31, 2026, Tri Chemical Laboratories Inc. holds 55.53M in cash and equivalents against 31.86M in total debt, resulting in a net debt position of -23.67M. Total book value stands at 210.74M, with working capital of 103.88M providing operational flexibility.
| Cash & Cash Equivalents | 55.53M |
| Total Debt | 31.86M |
| Net Debt | -23.67M |
| Equity (Book Value) | 210.74M |
| Book Value Per Share | 6.48 |
| Working Capital | 103.88M |
Tri Chemical Laboratories Inc.'s most recent stock split took place on January 28, 2021 with a 1:4 split ratio.
| Last Split Date | 1/28/2021 |
| Split Ratio | 1:4 |
Already premium?